Analysis of Debt
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- Balance Sheet: Assets
- Analysis of Profitability Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Dividend Discount Model (DDM)
- Total Asset Turnover since 2005
- Price to Sales (P/S) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Total Debt (Carrying Amount)
Regeneron Pharmaceuticals Inc., balance sheet: debt
US$ in thousands
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Finance lease liabilities, current portion
- Data is only available for the year ending December 31, 2021, where the value is 719,700 thousand US dollars. No information is provided for the other years, indicating either an absence of current portion finance lease liabilities or missing data for those periods.
- Long-term debt
- The long-term debt amount shows a consistent but very gradual increase over the five-year period. It starts at 1,978,500 thousand US dollars at the end of 2020 and steadily rises each year, reaching 1,984,400 thousand US dollars by the end of 2024. The annual increments are minimal, suggesting stable debt management without significant new borrowings or repayments impacting the long-term debt substantially.
- Finance lease liabilities, excluding current portion
- The finance lease liabilities excluding the current portion have a stable trend with a slight increase noted between 2020 and 2022. The value is 717,200 thousand US dollars at the end of 2020, rising marginally to 720,000 thousand US dollars in 2022. It then remains constant at 720,000 thousand US dollars through 2023 and 2024, indicating stable lease obligations without major adjustments.
- Total long-term debt and finance lease liabilities (carrying amount)
- This aggregate measure shows a very slight upward trend across the period from 2020 to 2024. It starts from 2,695,700 thousand US dollars at the end of 2020 and increases gradually each year to 2,704,400 thousand US dollars by the end of 2024. The steady figures reflect stability in the overall long-term liabilities, with no significant fluctuations or sudden increases, which may suggest consistent financial strategy and management.
Total Debt (Fair Value)
| Dec 31, 2024 | |
|---|---|
| Selected Financial Data (US$ in thousands) | |
| Long-term debt | |
| Finance lease liabilities | |
| Total long-term debt and finance lease liabilities (fair value) | |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | |
Based on: 10-K (reporting date: 2024-12-31).
Weighted-average Interest Rate on Debt
Weighted-average interest rate on debt and finance lease liabilities:
| Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
|---|---|---|---|
| Total | |||
Based on: 10-K (reporting date: 2024-12-31).
1 US$ in thousands
2 Weighted-average interest rate = 100 × ÷ =